Competing interests:
My group has received funding from a variety of sources including UK research councils such as the MRC and overseas charities such as the Washington DC based CMSRI to undertake research on the safety of aluminium adjuvants used in vaccines.
Rapid Response:
Re: Restoring invisible and abandoned trials: a call for people to publish the findings
Dear Editor
May I concur with this 'call to action' and add my small contribution published in the Lancet Infectious Diseases.
The article can be accessed here; https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(16)30546-1/fulltext
Competing interests: My group has received funding from a variety of sources including UK research councils such as the MRC and overseas charities such as the Washington DC based CMSRI to undertake research on the safety of aluminium adjuvants used in vaccines.